LIFE HEALTHCARE GROUP HOLDINGS LIMITED - Vesting of shares to directors, prescribed officers and directors of a major subsidiary and the company secretary

Vesting of shares to directors, prescribed officers and directors of a major subsidiary and the company secretary

LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
JSE and A2X share code: LHC
("Life Healthcare" or "the Company")

LIFE HEALTHCARE FUNDING LIMITED
(Incorporated in the Republic of South Africa with limited liability)
(Registration number: 2016/273566/06)
LEI: 3789SJPQJZF8ZYXTZ394
Bond company code: LHFI

VESTING OF SHARES TO DIRECTORS, PRESCRIBED OFFICERS AND DIRECTORS OF A MAJOR SUBSIDIARY AND THE COMPANY SECRETARY

Long-Term Incentive Plan ("the LTIP")

Shareholders and noteholders are reminded that on 8 February 2023, the Executive Directors, the
Prescribed Officer, the Company Secretary and the Directors of the major subsidiaries of the Company
accepted rights to participate in the Company's Long-Term Incentive Plan (LTIP) – 2023 allocation.

The specified performance conditions related to this scheme have been met and vesting occurred on
31 December 2025.

The value of the vested performance shares in respect of the LTIP 2023 allocation was based on the
performance outcomes and the 30-day VWAP as at 31 December 2025. The after-tax value has been
utilised to purchase the shares. The number of LHC ordinary shares per participant was based on the
average VWAP purchase price from 17 to 22 December 2025 of R11.40 (allocation value).

The number of shares to be delivered (off-market) to the personal trading account for the Executive
Directors, the Prescribed Officer, the Company Secretary and the Directors of the major subsidiaries of
the Company, respectively, is as follows:

                                                                        Number of Life   Total allocation
 Recipients                        Details of Recipients                Healthcare       values at LHC share
                                                                        shares           price of R11.40

 Peter Gerard Wharton-Hood         Director                             1 041 648        R11 878 321,38
 Petrus Phillippus van der         Director                             741 397          R8 454 444,77
 Westhuizen
 Adam Pyle                         Prescribed Officer                   525 396          R5 991 294,85
 Kurt Wylie                        Director of a major                  320 368          R3 653 286,12
                                   subsidiary of the Company
 Craig Koekemoer                   Director of a major                  369 784          R4 216 795,55
                                   subsidiary of the Company
 Joshila Ranchhod                  Company Secretary                    220 766          R2 517 480,72


The nature of the interest in relation to the above vestings is direct beneficial.

Clearance to deal has been obtained in terms of the JSE Listings Requirements.

Dunkeld
9 January 2026

Equity Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Debt Sponsor
Questco Corporate Advisory

Date: 09-01-2026 03:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.